Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers.
Timin AS, Peltek OO, Zyuzin MV, Muslimov AR, Karpov TE, Epifanovskaya OS, Shakirova AI, Zhukov MV, Tarakanchikova YV, Lepik KV, Sergeev VS, Sukhorukov GB, Afanasyev BV. Timin AS, et al. Among authors: afanasyev bv. ACS Appl Mater Interfaces. 2019 Apr 10;11(14):13091-13104. doi: 10.1021/acsami.8b22685. Epub 2019 Mar 27. ACS Appl Mater Interfaces. 2019. PMID: 30883080
Mesenchymal Stem Cell Magnetization: Magnetic Multilayer Microcapsule Uptake, Toxicity, Impact on Functional Properties, and Perspectives for Magnetic Delivery.
Lepik KV, Muslimov AR, Timin AS, Sergeev VS, Romanyuk DS, Moiseev IS, Popova EV, Radchenko IL, Vilesov AD, Galibin OV, Sukhorukov GB, Afanasyev BV. Lepik KV, et al. Among authors: afanasyev bv. Adv Healthc Mater. 2016 Dec;5(24):3182-3190. doi: 10.1002/adhm.201600843. Epub 2016 Nov 18. Adv Healthc Mater. 2016. PMID: 27860430
Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.
Lepik KV, Mikhailova NB, Moiseev IS, Kondakova EV, Tsvetkova LA, Zalyalov YR, Borzenkova ES, Babenko EV, Baykov VV, Markova IV, Afanasyev BV. Lepik KV, et al. Among authors: afanasyev bv. Leuk Lymphoma. 2019 Sep;60(9):2316-2319. doi: 10.1080/10428194.2019.1573368. Epub 2019 Feb 4. Leuk Lymphoma. 2019. PMID: 30712423 No abstract available.
High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide.
Moiseev IS, Babenko EV, Epifanovskaya OS, Sergeev VS, Dotcenko AA, Bakin EA, Surkova EA, Kuznetsova DA, Lapin SV, Pirogova OV, Alyanskii AL, Golovacheva AA, Darskaya EI, Morozova EV, Markova IV, Bondarenko SN, Afanasyev BV. Moiseev IS, et al. Among authors: afanasyev bv. Bone Marrow Transplant. 2020 Mar;55(3):544-552. doi: 10.1038/s41409-019-0665-3. Epub 2019 Sep 20. Bone Marrow Transplant. 2020. PMID: 31541204
103 results